Authors: Hughes, WT Shenep, JL Rodman, JH Fridland, A Willoughby, R Blanchard, S Purdue, L Coakley, DF Cundy, KC Culnane, M Zimmer, B Burchett, S Read, JS

Citation: Wt. Hughes et al., Single-dose pharmacokinetics and safety of the oral antiviral compound adefovir dipivoxil in children infected with human immunodeficiency virus type1, ANTIM AG CH, 44(4), 2000, pp. 1041-1046

Authors: Stiehm, ER Fletcher, CV Mofenson, LM Palumbo, PE Kang, MH Fenton, T Sapan, CV Meyer, WA Shearer, WT Hawkins, E Fowler, MG Bouquin, P Purdue, L Sloand, EM Nemo, GJ Wara, D Bryson, YJ Starr, SE Petru, A Burchett, S

Citation: Er. Stiehm et al., Use of human immunodeficiency virus (HIV) human hyperimmune immunoglobulinin HIV type 1-infected children (Pediatric AIDS Clinical Trials Group Protocol 273), J INFEC DIS, 181(2), 2000, pp. 548-554